Deep Health AI India Limited (BOM:539559)
India · Delayed Price · Currency is INR 1.940
-0.010 (-0.51%)
At close: Aug 21, 2026
Deep Health AI India Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 45.5 | 42.5 | 12.59 | 25.56 | 76.72 | 13.92 |
Other Revenue | -0.21 | - | 0 | 0 | - | - |
| 45.29 | 42.5 | 12.59 | 25.56 | 76.72 | 13.92 | |
Revenue Growth | 403.26% | 237.44% | -50.73% | -66.68% | 451.03% | 172.38% |
Cost of Revenue | - | - | 1.46 | 9.06 | 44.72 | 9.4 |
Gross Profit | 45.29 | 42.5 | 11.14 | 16.5 | 32 | 4.52 |
Selling, General & Admin | 1.95 | 1.88 | 2.29 | 3.74 | 2.43 | 1.87 |
Other Operating Expenses | 30.25 | 7.26 | 4.29 | 15.12 | 13.41 | 2.62 |
Operating Expenses | 32.26 | 9.23 | 6.69 | 18.98 | 15.9 | 4.51 |
Operating Income | 13.03 | 33.27 | 4.45 | -2.48 | 16.1 | 0.01 |
Interest Expense | -0.27 | -0.27 | -0.68 | -2.16 | -1.08 | - |
Interest & Investment Income | - | - | 7.41 | 10.71 | 2.4 | 2.13 |
Earnings From Equity Investments | -3.91 | -1.72 | 0.18 | -0.18 | - | - |
Other Non Operating Income (Expenses) | 42.4 | 42.4 | -0.25 | -0.23 | -0 | 0.29 |
EBT Excluding Unusual Items | 51.26 | 73.69 | 11.1 | 5.66 | 17.41 | 2.43 |
Gain (Loss) on Sale of Investments | - | - | 0.05 | 0.2 | -0.08 | 0.21 |
Gain (Loss) on Sale of Assets | - | - | -0 | - | - | - |
Asset Writedown | - | - | - | -0.07 | - | - |
Other Unusual Items | -57.72 | -57.72 | - | - | - | - |
Pretax Income | -6.46 | 15.97 | 11.14 | 5.79 | 17.33 | 2.65 |
Income Tax Expense | 4.32 | 4.63 | 2.38 | 1.62 | 4.77 | 0.68 |
Net Income | -10.78 | 11.34 | 8.77 | 4.17 | 12.56 | 1.97 |
Net Income to Common | -10.78 | 11.34 | 8.77 | 4.17 | 12.56 | 1.97 |
Net Income Growth | - | 29.37% | 110.27% | -66.82% | 537.46% | - |
Shares Outstanding (Basic) | 114 | 94 | 48 | 48 | 48 | 32 |
Shares Outstanding (Diluted) | 114 | 94 | 48 | 48 | 48 | 32 |
Shares Change | 117.04% | 96.65% | - | - | 50.16% | - |
EPS (Basic) | -0.09 | 0.12 | 0.18 | 0.09 | 0.26 | 0.06 |
EPS (Diluted) | -0.09 | 0.12 | 0.18 | 0.09 | 0.26 | 0.06 |
EPS Growth | - | -33.33% | 107.49% | -66.82% | 324.54% | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -36.53 | 1.87 | -54.25 | -0.25 | 5.18 |
Free Cash Flow Per Share | - | -0.39 | 0.04 | -1.13 | -0.01 | 0.16 |
Gross Margin | 100.00% | 100.00% | 88.43% | 64.54% | 41.71% | 32.47% |
Operating Margin | 28.78% | 78.29% | 35.32% | -9.71% | 20.98% | 0.08% |
Profit Margin | -23.80% | 26.68% | 69.59% | 16.31% | 16.37% | 14.15% |
Free Cash Flow Margin | - | -85.95% | 14.87% | -212.23% | -0.32% | 37.23% |
EBITDA | 13.11 | 33.36 | 4.56 | -2.36 | 16.17 | 0.03 |
EBITDA Margin | 28.94% | 78.48% | 36.20% | -9.24% | 21.07% | 0.20% |
D&A For EBITDA | 0.07 | 0.08 | 0.11 | 0.12 | 0.07 | 0.02 |
EBIT | 13.03 | 33.27 | 4.45 | -2.48 | 16.1 | 0.01 |
EBIT Margin | 28.78% | 78.29% | 35.32% | -9.71% | 20.98% | 0.08% |
Effective Tax Rate | - | 29.01% | 21.34% | 27.98% | 27.52% | 25.51% |
Revenue as Reported | 87.7 | 84.9 | 20.05 | 36.47 | 79.2 | 16.56 |
Advertising Expenses | - | - | 0.08 | 0.11 | 5.06 | 0.03 |